Rhinocerebral mucormycosis in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 36, Issue 4, 2003, Pages 266-269

  Khor, Boon Siang ^a   Lee, Ming Hsun ^a   Leu, Hsieh Shong ^a   Liu, Jien Wei ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Amphotericin B; Debridement; Diabetes mellitus; Rhinocerebral mucormycosis

Indexed keywords

AMPHOTERICIN B;

ABSIDIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; DEBRIDEMENT; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; EYE DISEASE; FEMALE; HEADACHE; HUMAN; LABORATORY TEST; MALE; MUCOR; MUCORMYCOSIS; NOSE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; RETROSPECTIVE STUDY; RHINOCEREBRAL MUCORMYCOSIS; RHIZOMUCOR; RHIZOPUS; SURVIVAL RATE; SYMPTOM; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIFUNGAL AGENTS; BRAIN DISEASES; COMMUNITY HEALTH CENTERS; DEBRIDEMENT; DIABETES COMPLICATIONS; EYE; FEMALE; FEVER; HEADACHE; HUMANS; MALE; MIDDLE AGED; MUCORMYCOSIS; NOSE; NOSE DISEASES; RETROSPECTIVE STUDIES; TAIWAN; TREATMENT OUTCOME; UNCONSCIOUSNESS;

EID: 0345763273     PISSN: 02532662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sugar AM. Mucormycosis. Clin Infect Dis 1992;14(Suppl): S126-9.
2. Armstrong D. Treatment of opportunistic fungal infections. Clin Infect Dis 1993;16:1-9.
3. Adam RD, Hunter G, DiTomasso J, Comerci G Jr. Mucormycosis: emerging prominence of cutaneous infection. Clin Infect Dis 1994;19:67-76.
4. Parfrey NA. Improved diagnosis and prognosis of mucormycosis: a clinicopathologic study of 33 cases. Medicine 1986;65:113-23.
5. Kudsk KA, Laulederkind A, Hanna MK. Most infectious complications in parenterally fed trauma patients are not due to elevated blood glucose levels. J Parenter Enteral Nutri 2001;25:174-9.
6. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryn Clin North Am 2000;33:349-65.
7. Blitzer A, Lawson W, Meyes BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980;90:635-48.
8. Chinn RY, Diamond RD. Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: Relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun 1982;38:1123-9.
9. Meyer RD, Rosen P, Armstrong D. Phycomycosis complicating leukemia and lymphoma. Ann Intern Med 1972;77:871-9.
10. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care center. Clin Infect Dis 2000;30:851-6.
11. Funada H, Misawa T, Nakao S, Saga T, Hattori KI. The air crescent sign of invasive pulmonary mucormycosis in acute leukemia. Cancer 1984;53:2721-3.
12. Meyers BR, Wormser G, Hirischman SZ, Blitzer A. Rhinocerebral mucormycosis: premortem diagnosis and therapy. Arch Intern Med 1979;139:557-60.
13. Del Valle Zapico A, Rubio Suarez A, Mellado Encinas P, Morales Angulo C, Cabrera Pozuelo E. Mucormycosis of the sphenoid sinus in an otherwise healthy patient: case report and literature review. J Laryngol Otol 1996;110:471-3.
14. Rangel-Guerra RA, Martinez HR, Saenz C, Bosques-Padilla F, Estrada-Bellmann I. Rhinocerebral and systemic mucormycosis: clinical experience with 36 cases. J Neurol Sci 1996;143:19-30.